Literature DB >> 26284685

Increased Dietary Salt Intake Does Not Influence Influenza A Virus-Induced Disease Severity in Mice.

Samuel Amoah1, Weiping Cao1, Priya Ranjan1, Patricia Greer2, Wun-Ju Shieh2, Sherif R Zaki2, Jacqueline M Katz1, Suryaprakash Sambhara1, Shivaprakash Gangappa1.   

Abstract

Influenza viruses are pathogens of significant public health importance. The influence of nutritional status on severity of disease has become increasingly recognized. In particular, high dietary salt intake has been linked to cardiovascular disease, but the effects on infectious diseases have not been studied. This study investigated the impact on influenza-induced morbidity and mortality in mice fed isocaloric diets containing 10-fold increments of sodium by altering the salt levels. Following infection, despite higher levels of IFN-gamma cytokine in the lung as well as virus-neutralizing antibody in the serum of mice fed the lowest salt level, the amounts of dietary salt intake had no substantial impact on the disease severity or the ability to respond immunologically to the infection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26284685      PMCID: PMC5737935          DOI: 10.1089/vim.2015.0037

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  21 in total

Review 1.  Dietary salt reduction or exclusion for allergic asthma.

Authors:  K D Ardern
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 2.  Factors associated with severe illness in pandemic 2009 influenza a (H1N1) infection: implications for triage in primary and secondary care.

Authors:  Anika Singanayagam; Aran Singanayagam; Victoria Wood; James D Chalmers
Journal:  J Infect       Date:  2011-08-03       Impact factor: 6.072

Review 3.  Salt in health and disease--a delicate balance.

Authors:  Theodore A Kotchen; Allen W Cowley; Edward D Frohlich
Journal:  N Engl J Med       Date:  2013-03-28       Impact factor: 91.245

4.  PCSK9-deficiency does not alter blood pressure and sodium balance in mouse models of hypertension.

Authors:  Jean-Mathieu Berger; Nathalie Vaillant; Cédric Le May; Carolina Calderon; Jeremy Brégeon; Xavier Prieur; Juliette Hadchouel; Gervaise Loirand; Bertrand Cariou
Journal:  Atherosclerosis       Date:  2015-01-19       Impact factor: 5.162

5.  2009 Pandemic influenza A virus subtype H1N1 in Morocco, 2009-2010: epidemiology, transmissibility, and factors associated with fatal cases.

Authors:  Amal Barakat; Hassan Ihazmad; Fatima El Falaki; Stefano Tempia; Imad Cherkaoui; Rajae El Aouad
Journal:  J Infect Dis       Date:  2012-12-15       Impact factor: 5.226

Review 6.  Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis.

Authors:  L Fezeu; C Julia; A Henegar; J Bitu; F B Hu; D E Grobbee; A-P Kengne; S Hercberg; S Czernichow
Journal:  Obes Rev       Date:  2011-04-04       Impact factor: 9.213

7.  Sodium intake and mortality in the NHANES II follow-up study.

Authors:  Hillel W Cohen; Susan M Hailpern; Jing Fang; Michael H Alderman
Journal:  Am J Med       Date:  2006-03       Impact factor: 4.965

8.  Influenza-associated hospitalizations in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Carolyn B Bridges; Nancy J Cox; Keiji Fukuda
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

9.  Impaired sodium excretion and salt-sensitive hypertension in corin-deficient mice.

Authors:  Wei Wang; Jianzhong Shen; Yujie Cui; Jingjing Jiang; Shenghan Chen; Jianhao Peng; Qingyu Wu
Journal:  Kidney Int       Date:  2012-03-14       Impact factor: 10.612

10.  Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome.

Authors:  Wanna Hanshaoworakul; James Mark Simmerman; Ubolrat Narueponjirakul; Wiwan Sanasuttipun; Vivek Shinde; Suchada Kaewchana; Darin Areechokechai; Jens Levy; Kumnuan Ungchusak
Journal:  PLoS One       Date:  2009-06-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.